التفاصيل البيبلوغرافية
| العنوان: |
Connected Insulin Pens and Caps: An Expert's Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN). |
| المؤلفون: |
Tejera-Pérez, Cristina, Chico, Ana, Azriel-Mira, Sharona, Lardiés-Sánchez, Beatriz, Gomez-Peralta, Fernando, Jesús, Amor Fernández Antonio, Amparo, Bartual Rodrigo, Virginia, Bellido, Diego, Bellido Guerrero, Antonio, Botana López Manuel, Miguel, Brito Sanfiel, Gloria, Canovas Molina, Daniel, Cepero Garcia, Ana, Chico Ballesteros, Ignacio, Conget Donlo, Antonio, de Luis Román Daniel, María, Durán Martínez, Alejandra, Duran Rodriguez-Hervada, Javier, Escalada San Martin Francisco, Carlos, Fernández García José |
| المصدر: |
Diabetes Therapy; Jul2023, Vol. 14 Issue 7, p1077-1091, 15p |
| مصطلحات موضوعية: |
INSULIN therapy, INSULIN pumps, PEOPLE with diabetes, TYPE 1 diabetes, GLYCEMIC control, TYPE 2 diabetes, ENDOCRINOLOGISTS |
| مستخلص: |
Undoubtedly, technological advances have revolutionised diabetes management in recent years. The development of advanced closed hybrid loop insulin pumps or continuous glucose monitoring (CGM) systems, among others, have increased the quality of life and improved glycaemic control of people with diabetes. However, only some patients have access to such technology, and only some want to use it. CGM has become much more widespread, but in terms of insulin delivery, most people with type 1 diabetes (T1D) and almost all people with type 2 diabetes (T2D) on insulin therapy are treated with multiple-dose insulin injections (MDI) rather than an insulin pump. For these patients, using connected insulin pens or caps has shown benefits in reducing missed insulin injections and promoting correct administration over time. In addition, using these devices improves the quality of life and user satisfaction. The integration of insulin injection and CGM data facilitates both users and the healthcare team to analyse glucose control and implement appropriate therapeutic changes, reducing therapeutic inertia. This expert's recommendation reviews the characteristics of the devices marketed or in the process of being marketed and their available scientific evidence. Finally, it suggests the profile of users and professionals who would benefit most, the barriers to its generalisation and the changes in the care model that implementing these devices can bring with it. [ABSTRACT FROM AUTHOR] |
|
Copyright of Diabetes Therapy is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder